Abstract: An apparatus and use of the apparatus for monitoring a current-carrying device wherein at least one acceleration sensor produces acceleration measurement values and a communication device transmits produced acceleration measurement values. A power supply unit is for the acceleration sensor and the communication device. The power supply unit includes an induction plate of a metallic material and a conductor loop extending around the induction plate and produces a power supply for the acceleration sensor and the communication device exclusively through induction from an electromagnetic alternating field of the current-carrying device. The apparatus can be positioned in a closed housing having a housing wall and the induction plate can be at least a subregion of the housing wall.

Abstract: A housing, which is provided for incorporating a surface lighting element in a wall, includes a base intended to be fixed in the wall and a flap for receiving the surface lighting element. The flap receives the surface lighting element on its face directed toward the outside of the housing and is mounted to pivot on the base by at least one removable link axis making it possible to dismantle and reassemble the flap relative to the base.

Abstract: Described herein are methods of treating inflammatory bowel disease (IBD) in a patient having IBD using SMAD7 antisense oligonucleotides.

Abstract: A housing, which is provided for incorporating a surface lighting element in a wall, includes a base intended to be fixed in the wall and a flap for receiving the surface lighting element. The flap receives the surface lighting element on its face directed toward the outside of the housing and is mounted to pivot on the base by at least one removable link axis making it possible to dismantle and reassemble the flap relative to the base.

Abstract: Triglyceride and other polyol ester PVC plasticizers can be produced by recovery of branched C6 to C9 aldehydes from a hydroformylation product, optional hydrogenation to the alcohol, oxidation to the acid with oxygen and/or air, recovery of the resulting acid, and esterification with glycerol, ethylene glycol, propylene glycol or mixtures thereof. The branched alkyl chains comprise at least 10% methyl branching. Special triglycerides are derived from branched aliphatic acids having alkyl chains with average carbon numbers from 6 to 9 and at least 10% methyl branching. These triglycerides are fast fusing plasticizers if before esterification with glycerol, an aryl acid is introduced together with the aliphatic acids.

Abstract: A computing system for converting software code into an executable program include an expanding preprocessor that receives software code including debug statements and expands the debug statements into conditions that include a static variable and that must be met before a trace contained in the statement is executed, the expanding preprocessor creating an expanded code output. The system also includes a replacement preprocessor coupled to the expanding preprocessor and receiving the expanded code, the replacement preprocessor forming replaced code by replacing one or more occurrences of the static variables with a unique variable name and a compiler that compiles the replacement code to create an executable.

Abstract: The present invention relates to alcohols and in particular to C4 to C15 alcohols that are used in the production of esters.

Abstract: A method, apparatus, and computer program product for scheduling stream-based applications in a distributed computer system with configurable networks are provided. The method includes choosing, at a highest temporal level, jobs that will run, an optimal template alternative for the jobs that will run, network topology, and candidate processing nodes for processing elements of the optimal template alternative for each running job to maximize importance of work performed by the system. The method further includes making, at a medium temporal level, fractional allocations and re-allocations of the candidate processing elements to the processing nodes in the system to react to changing importance of the work. The method also includes revising, at a lowest temporal level, the fractional allocations and re-allocations on a continual basis to react to burstiness of the work, and to differences between projected and real progress of the work.

Abstract: Triglyceride and other polyol ester PVC plasticizers can be produced by recovery of branched C6 to C9 aldehydes from a hydroformylation product, optional hydrogenation to the alcohol, oxidation to the acid with oxygen and/or air, recovery of the resulting acid, and esterification with glycerol, ethylene glycol, propylene glycol or mixtures thereof. The branched alkyl chains comprise at least 10% methyl branching. Special triglycerides are derived from branched aliphatic acids having alkyl chains with average carbon numbers from 6 to 9 and at least 10% methyl branching. These triglycerides are fast fusing plasticisers if before esterification with glycerol, an aryl acid is introduced together with the aliphatic acids.

Abstract: A method, system and computer program product of setting up a virtual connection at run time. The method includes the steps of: analyzing a topology of an application to determine at least one port pair where the port pair comprises an output port of a first operator and an input port of a second operator; configuring a first auxiliary operator to receive data from a first operator; configuring a second auxiliary operator to send data to a second operator; deploying the first operator, the second operator, the first auxiliary operator and the second auxiliary operator; receiving a function address of the second auxiliary operator; and sending the function address of the second auxiliary operator to a first destination; where at least one of the steps is carried out using a computer device so that the virtual connection is setup at run time.

Abstract: A method, system and computer program product of setting up a virtual connection at run time. The method includes the steps of: analyzing a topology of an application to determine at least one port pair where the port pair comprises an output port of a first operator and an input port of a second operator; configuring a first auxiliary operator to receive data from a first operator; configuring a second auxiliary operator to send data to a second operator; deploying the first operator, the second operator, the first auxiliary operator and the second auxiliary operator; receiving a function address of the second auxiliary operator; and sending the function address of the second auxiliary operator to a first destination; where at least one of the steps is carried out using a computer device so that the virtual connection is setup at run time.

Abstract: The present invention provides nucleoside cyclic phosphoramidates of formula (I), pharmaceutical compositions comprising the compounds of formula (I) and methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection using the compounds of formula (I).

Abstract: The present invention relates to alcohols and in particular to C4 to C15 alcohols that are used in the production of esters.

Abstract: The present invention provides nucleoside aryl phosphoramidates of structural formula (I) which are precursors to inhibitors of RNA-dependent RNA viral polymerase. These compounds are precursors to inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as precursors to inhibitors of hepatitis C virus (HCV) NS5B polymerase, as precursors to inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside aryl phosphoramidates alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside aryl phosphoramidates of the present invention.

Abstract: A system in package (10) has a, preferably wireless, test controller (20) for testing each die (30) after it has been mounted onto the substrate of the system in package (10), and a faulty die (30) is repaired before a next die (30) is mounted onto the substrate (15). This way, the system in package (10) can be tested during the intermediate stages of its manufacturing, thus ensuring that all dies (30) function correctly before sealing the dies in the single package. Consequently, a method for manufacturing a system in package (10) is obtained that has an improved yield compared to known manufacturing methods.

Abstract: One embodiment of the present invention provides a system for location labeling. During operation, the system collects contextual information recorded by one or more components located on a computing device associated with a user, and determines whether the computing device is stationary based on collected information. Responsive to the computing device being stationary, the system allows the user to provide a location label.

Abstract: A computing system for converting software code into an executable program include an expanding preprocessor that receives software code including debug statements and expands the debug statements into conditions that include a static variable and that must be met before a trace contained in the statement is executed, the expanding preprocessor creating an expanded code output. The system also includes a replacement preprocessor coupled to the expanding preprocessor and receiving the expanded code, the replacement preprocessor forming replaced code by replacing one or more occurrences of the static variables with a unique variable name and a compiler that compiles the replacement code to create an executable.

Abstract: The present invention provides nucleoside aryl phosphoramidates of structural formula (I) which are precursors to inhibitors of RNA-dependent RNA viral polymerase. These compounds are precursors to inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as precursors to inhibitors of hepatitis C virus (HCV) NS5B polymerase, as precursors to inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside aryl phosphoramidates alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside aryl phosphoramidates of the present invention.

Abstract: The present invention provides nucleoside cyclic phosphoramidates of structural formula (I) which are precursors to inhibitors of RNA-dependent RNA viral polymerase. These compounds are precursors to inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as pre-cursors to inhibitors of hepatitis C virus (HCV) NS5B polymerase, as precursors to inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside cyclic phosphoramidates alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside cyclic phosphoramidates of the present invention.

Abstract: All catalytic process for producing white oils is provided. More particularly, medicinal grade white oils are produced from a process including hydrotreating and/or hydrocracking, catalytic dewaxing followed by hydrofinishing to produce a medicinal white oil.